Elanco Animal Health (ELAN) Ratios
Elanco Animal Health Ratios
MX:ELAN's free cash flow for Q2 2026 was $244.00M. For the 2026 fiscal year, MX:ELAN's free cash flow was decreased by $-33.00M and operating cash flow was $277.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.17 | 2.44 | 2.75 | 1.93 | 1.99 |
| Quick Ratio | 1.08 | 1.25 | 1.35 | 1.02 | 1.16 |
| Cash Ratio | 0.34 | 0.36 | 0.28 | 0.20 | 0.39 |
| Solvency Ratio | 0.07 | 0.15 | -0.07 | 0.07 | 0.03 |
| Operating Cash Flow Ratio | 0.35 | 0.41 | 0.22 | 0.27 | 0.29 |
| Short-Term Operating Cash Flow Coverage | 7.57 | 12.30 | 7.13 | 1.16 | 1.64 |
| Net Current Asset Value | $ -3.35B | $ -3.30B | $ -4.73B | $ -4.92B | $ -5.70B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.34 | 0.40 | 0.38 | 0.38 |
| Debt-to-Equity Ratio | 0.61 | 0.71 | 0.93 | 0.80 | 0.84 |
| Debt-to-Capital Ratio | 0.38 | 0.41 | 0.48 | 0.44 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.38 | 0.41 | 0.48 | 0.43 | 0.45 |
| Financial Leverage Ratio | 2.04 | 2.07 | 2.31 | 2.13 | 2.19 |
| Debt Service Coverage Ratio | 2.27 | 3.50 | -0.83 | 1.34 | 0.89 |
| Interest Coverage Ratio | 1.15 | 0.74 | 1.18 | 1.50 | 1.15 |
| Debt to Market Cap | 0.36 | 0.72 | 0.79 | 0.98 | 0.46 |
| Interest Debt Per Share | 8.54 | 9.43 | 12.29 | 12.48 | 13.51 |
| Net Debt to EBITDA | 5.14 | 2.59 | -24.21 | 6.34 | 13.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.48% | 43.01% | 43.88% | 44.66% | 43.58% |
| EBIT Margin | -0.08% | 18.63% | -20.78% | 4.17% | -6.44% |
| EBITDA Margin | 14.34% | 33.54% | -5.07% | 19.63% | 8.59% |
| Operating Profit Margin | 5.34% | 5.65% | 7.38% | 8.71% | 6.38% |
| Pretax Profit Margin | -4.75% | 10.99% | -27.05% | -1.63% | -11.99% |
| Net Profit Margin | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% |
| Continuous Operations Profit Margin | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% |
| Net Income Per EBT | 103.57% | 69.26% | 103.01% | 108.33% | 84.59% |
| EBT Per EBIT | -88.89% | 194.42% | -366.56% | -18.75% | -187.83% |
| Return on Assets (ROA) | -1.74% | 2.68% | -8.57% | -0.50% | -2.93% |
| Return on Equity (ROE) | -3.54% | 5.54% | -19.78% | -1.07% | -6.43% |
| Return on Capital Employed (ROCE) | 2.14% | 2.22% | 2.48% | 2.78% | 2.05% |
| Return on Invested Capital (ROIC) | 2.13% | 1.53% | 2.48% | 2.71% | 1.70% |
| Return on Tangible Assets | -4.49% | 7.48% | -25.79% | -1.68% | -10.24% |
| Earnings Yield | -2.07% | 5.65% | -16.78% | -1.31% | -3.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.02 | 5.01 | 4.37 | 4.40 | 4.63 |
| Payables Turnover | 7.24 | 8.55 | 9.18 | 6.26 | 6.46 |
| Inventory Turnover | 1.53 | 1.61 | 1.43 | 1.59 | 1.96 |
| Fixed Asset Turnover | 3.35 | 4.47 | 4.31 | 4.42 | 4.52 |
| Asset Turnover | 0.35 | 0.35 | 0.31 | 0.28 | 0.29 |
| Working Capital Turnover Ratio | 2.51 | 2.18 | 2.36 | 2.75 | 3.21 |
| Cash Conversion Cycle | 260.27 | 257.23 | 299.16 | 254.57 | 208.44 |
| Days of Sales Outstanding | 72.77 | 72.85 | 83.46 | 82.91 | 78.76 |
| Days of Inventory Outstanding | 237.90 | 227.08 | 255.46 | 229.98 | 186.17 |
| Days of Payables Outstanding | 50.40 | 42.70 | 39.75 | 58.32 | 56.49 |
| Operating Cycle | 310.67 | 299.93 | 338.92 | 312.89 | 264.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.13 | 1.10 | 0.55 | 0.93 | 0.99 |
| Free Cash Flow Per Share | 0.57 | 0.80 | 0.24 | 0.55 | 0.59 |
| Dividend Paid and CapEx Coverage Ratio | 2.03 | 3.68 | 1.76 | 2.46 | 2.45 |
| Capital Expenditure Coverage Ratio | 2.03 | 3.68 | 1.76 | 2.46 | 2.45 |
| Operating Cash Flow Coverage Ratio | 0.14 | 0.13 | 0.05 | 0.08 | 0.08 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.12 | 0.06 | 0.10 | 0.10 |
| Free Cash Flow Yield | 2.53% | 6.59% | 1.60% | 4.49% | 2.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -48.15 | 17.81 | -5.96 | -76.50 | -28.63 |
| Price-to-Sales (P/S) Ratio | 2.38 | 1.35 | 1.66 | 1.35 | 2.90 |
| Price-to-Book (P/B) Ratio | 1.72 | 0.98 | 1.18 | 0.82 | 1.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 39.55 | 15.18 | 62.69 | 22.27 | 48.35 |
| Price-to-Operating Cash Flow Ratio | 20.06 | 11.06 | 27.07 | 13.20 | 28.63 |
| Price-to-Earnings Growth (PEG) Ratio | 0.28 | -0.14 | -0.00 | 0.90 | 1.21 |
| Enterprise Value Multiple | 21.75 | 6.61 | -56.95 | 13.23 | 47.70 |
| Enterprise Value | 14.71B | 9.84B | 12.76B | 11.46B | 19.51B |
| EV to EBITDA | 21.75 | 6.61 | -56.95 | 13.23 | 47.70 |
| EV to Sales | 3.12 | 2.22 | 2.89 | 2.60 | 4.09 |
| EV to Free Cash Flow | 51.78 | 24.96 | 109.04 | 42.75 | 68.21 |
| EV to Operating Cash Flow | 26.26 | 18.18 | 47.07 | 25.35 | 40.39 |
| Tangible Book Value Per Share | -3.30 | -4.05 | -6.84 | -7.26 | -8.73 |
| Shareholders’ Equity Per Share | 13.19 | 12.34 | 12.64 | 14.93 | 15.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | 0.31 | -0.03 | -0.08 | 0.15 |
| Revenue Per Share | 9.50 | 8.99 | 8.97 | 9.03 | 9.78 |
| Net Income Per Share | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 |
| Tax Burden | 1.04 | 0.69 | 1.03 | 1.08 | 0.85 |
| Interest Burden | 56.00 | 0.59 | 1.30 | -0.39 | 1.86 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.07 | 0.07 | 0.08 |
| SG&A to Revenue | 0.30 | 0.30 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | -2.41 | 1.60 | -0.22 | -5.79 | -1.02 |
Currency in USD